EDH inks the deal for exclusive distribution of Elysia-Raytest products

EDH Nuclear Medicine and Healthcare Services is pleased to announce that they have entered into a strategic agreement with Elysia-Raytest S.A. that makes them their authorized distributor for selected countries. 

The deal involves the exclusive distribution and service support of  Elysia-Raytest products in the countries where EDH has active presence including but not limited to Albania, Azerbaijan, Bangladesh, Bosnia-Herzegovina, Croatia, Georgia, Jordan, Kyrgyzstan, Kosovo, Lebanon, Macedonia, Montenegro, Pakistan, Slovenia, Serbia, Turkey, Turkmenistan, Tajikistan, Uzbekistan as well as additional 16 non-exclusive countries.

“Elysia-Raytest is a highly innovative and progressive manufacturer and we are proud to be able to leverage our proven expertise and experience in nuclear medicine and oncology to help bring these virtues into focus. We have already been working with Elysia-Raytest in some selected countries and unique projects and this expansion of our collaboration enables EDH to serve to a broader geographical reach with state of the art Products. We are also keen to add new complimentary products to our portfolio with other great manufacturers in very near future which will help us to create an integrated solution platform as being the most innovative service integrator” commented Hasan Ulas Ozcan, General Manager of EDH Nuclear Medicine and Healthcare Services.

About EDH Nuclear Medicine and Healthcare Services:

EDH is  the most innovative Service Integrator in the field of nuclear medicine and oncology offering state of the art solutions. EDH currently handles sales and marketing of selected radiopharmaceuticals and radioisotopes as well as sales and after sales support of equipment used in nuclear medicine and niche segments of oncology. EDH also offers turnkey setup of  radiopharmaceutical manufacturing plants and nuclear medicine departments compliant to EU /USFDA GMP .

About Elysia-Raytest:

Elysia-Raytest is a competent and reliable partner for the global community in nuclear medicine and Radio Therapy synthesis and Quality Control. The reputation of Elysia- Raytest is based on the supply of high-quality hard- and software solutions and services for quality control (QC) laboratories and PET tracer production synthesizers . From metabolism research in pharmaceutical and agrochemical research to nuclear medicine and PET, Elysia-Raytest supplies state-of-the-art devices and integral GMP solutions.

Elysia-Raytest GmbH achieved ISO 9001 certification which is the highest quality system of the global ISO 9000 series of quality assurance standards. It was developed by the International Organization for Standardization (ISO).

With ISO 9001 certification, Elysia-Raytest established a definitive quality process that ensures reliability and consistency from the initial idea up to the release of innovative new products, furthering the company’s position within the international scientific community.